SAME

Tried SAME? Be part of the collective knowledge. Share your experience - your insights help others on their journey.

What Is SAME?

Supplement

S-Adenosylmethionine (SAMe) is a naturally occurring molecule in the body that serves as a methyl donor in numerous biochemical reactions. It plays a critical role in neurotransmitter synthesis, liver function, and methylation processes. SAMe is primarily used as a supplement for depression, liver health, joint pain (osteoarthritis), and mood disorders.

SAME Research & Studies

01 Efficacy of a food supplement based on S-adenosyl methionine and probiotic strains in subjects with subthreshold depression and mild-to-moderate depression: A monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial

A combination of SAMe (200mg/day) and probiotics significantly reduced depression symptoms on both HAM-D and PHQ-9 scales compared to placebo in subjects with subthreshold and mild-to-moderate depression over three months.

View Study (PubMed)
02 S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review

Systematic review found SAMe showed antidepressant effects in several trials, with some studies showing significant improvement over placebo, though results were mixed when compared to other antidepressants.

View Study (PubMed)
03 Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial

Study of 107 patients found no significant difference between 800mg/day SAMe and placebo as adjunctive treatment for depression, with both groups showing 50%+ response rates due to high placebo response.

View Study (PubMed)
04 Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis

Meta-analysis found SAMe was more effective than placebo in reducing functional limitation in osteoarthritis patients and appeared comparable to NSAIDs for pain relief, with fewer adverse effects.

View Study (PubMed)
05 S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review

Systematic review of 15 high-quality studies found SAMe effective in improving liver-related parameters with few adverse events, primarily mild gastrointestinal complaints.

View Study (PubMed)
06 S-adenosylmethionine and depression

Review of clinical studies found SAMe safe and effective in treating mild and moderate depression, with potential as complementary or alternative therapy to traditional antidepressants.

View Study (PubMed)

SAME User Reviews & Experiences

68% Mixed

*Based on large scale analysis of publicly available user experiences

User sentiment is genuinely mixed, with some reporting significant mood improvements and others experiencing no effects or side effects. Many users note SAMe works well for specific conditions like liver health and joint pain, but effectiveness for depression varies considerably, with some experiencing emotional blunting or no response.

SAME Benefits, Dosage & Side Effects

Effects
  • Mood Enhancement: Users report improved mood, reduced depression symptoms, and better emotional stability, though effects vary significantly between individuals
  • Joint and Pain Relief: Several users note improvements in joint health, reduced inflammation, and pain relief from osteoarthritis
  • Liver Support: Users taking SAMe for liver health report improved liver markers and overall liver function
  • Energy and Motivation: Some users experience increased energy levels and motivation, particularly those with depression or fatigue
Effectiveness
  • Individual Variation: Effectiveness varies dramatically between users, with some experiencing life-changing benefits while others notice no effects whatsoever
  • Depression Treatment: Results for depression are mixed in both research and user reports, with some finding it as effective as SSRIs and others finding it ineffective or inferior to prescription medications
  • Combined Therapy: SAMe appears to work better when combined with other supplements (probiotics, B-vitamins) or as adjunctive therapy rather than standalone treatment
  • Onset Time: Users report effects can take 2-4 weeks to become noticeable, with some experiencing immediate benefits and others requiring longer supplementation periods
Dosage & Administration
  • Standard Depression Dose: 200-800mg daily is commonly used for mood support, with some clinical trials using up to 1600mg daily for major depressive disorder
  • Liver Health Dose: 1000-1200mg daily is frequently mentioned for liver support and detoxification purposes
  • Timing: Most users take SAMe in the morning on an empty stomach for best absorption, as it can be activating for some people
  • Forms: Enteric-coated tablets and sublingual forms (like methylcobalamin) are preferred for better absorption and reduced gastrointestinal upset
Side Effects
  • Gastrointestinal Issues: Mild nausea, upset stomach, and digestive discomfort are the most commonly reported side effects, particularly at higher doses
  • Emotional Blunting: Some users report feeling emotionally flat, numb, or experiencing reduced emotional range while taking SAMe
  • Activation/Anxiety: A subset of users experience increased anxiety, restlessness, or overstimulation, particularly those sensitive to methylation
  • Serotonin Concerns: Rare reports of serotonin syndrome-like symptoms when combined with other antidepressants, requiring medical supervision when used with SSRIs
Availability & Sourcing
  • Over-the-Counter: SAMe is widely available as an OTC supplement in the US and many countries, found in pharmacies and health food stores
  • Quality Concerns: Users emphasize importance of choosing reputable brands with enteric-coated formulations to ensure stability and absorption
  • Cost Factor: SAMe is relatively expensive compared to other supplements, with quality products costing $30-60 per month at therapeutic doses

Related Compounds

Community Reviews

Share your experience with SAME and help others make informed decisions.

Write a Review

Sign in to leave a review

Recent Reviews

Loading reviews...